Biofrontera (BFRI) EBT Margin (2020 - 2026)
Biofrontera (BFRI) reported EBT Margin of -4.84% for Q2 2026, up 53.89 percentage points from -58.73% a year earlier.
Powered by 
Analysis
Biofrontera (BFRI) EBT Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Biofrontera's EBT Margin came in at -15.26%, up 27.02 percentage points year-over-year; for FY2025, it came in at -25.20%, up 22.32 percentage points from FY2024.
- EBT Margin has a five-year change of +32.75 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -47.53% in FY2024 (+11.52 pp), -59.04% in FY2023 (-56.92 pp), -2.12% in FY2022 (+154.13 pp) and -156.25% in FY2021 (-98.30 pp).
- Five-year quarterly EBT Margin spans a low of -369.31% in Q3 2021 and a high of 57.34% in Q1 2022.
- Year over year, EBT Margin gained in four of the last seven quarters, with an average year-over-year change of +8.16 percentage points.
- The high point for year-over-year EBT Margin in five years was Q3 2022 (a gain of 309.96 percentage points); the low point was Q3 2021 (a drop of 279.40 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Biofrontera | 16.05 Mn | -5.74 Mn | 9.59 Mn | -4.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.84% |
| Dec 31, 2025 | 32.98% |
| Sep 30, 2025 | -95.06% |
| Jun 30, 2025 | -58.73% |
| Mar 31, 2025 | -48.95% |
| Dec 31, 2024 | -11.14% |
| Sep 30, 2024 | -62.87% |
| Jun 30, 2024 | -3.02% |
| Mar 31, 2024 | -131.90% |
| Dec 31, 2023 | 33.22% |
| Sep 30, 2023 | -71.28% |
| Jun 30, 2023 | -167.97% |
| Mar 31, 2023 | -85.57% |
| Dec 31, 2022 | -27.44% |
| Sep 30, 2022 | -59.35% |
| Jun 30, 2022 | -19.07% |
| Mar 31, 2022 | 57.34% |
| Dec 31, 2021 | -158.16% |
| Sep 30, 2021 | -369.31% |
| Jun 30, 2021 | -61.78% |
API Access
Biofrontera EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=BFRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "BFRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=BFRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();